Reducing Sedentary Behaviour in Office Workers With a HAPA mHealth Intervention and a Just In-Time Adaptive Intervention
Launched by WESTERN UNIVERSITY, CANADA · Oct 29, 2021
Trial Information
Current as of June 28, 2025
Unknown status
Keywords
ClinConnect Summary
This three-arm repeated measure randomized control trial will randomize participants into two intervention groups and one control group to attempt to reduce sedentary behaviour in office workers. The study will last for four weeks, the first week of the study will be used for baseline measurement and the remaining three weeks used for the intervention.
Participants will be full time office workers primarily recruited from large businesses and corporations. The primary purpose of the study will be to decrease sedentary behaviour in office workers from pre- to post-intervention by breaking u...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • full-time employee in a desk-based office job (work from home accepted)
- • have access to a mobile phone with internet connection
- • can read and write in English
- Exclusion Criteria:
- • any medical or physical limitation that would prevent standing, stretching, and/or light physical activity
About Western University, Canada
Western University, located in Canada, is a leading research institution committed to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and research teams to conduct high-quality studies that address pressing medical challenges. Western University is dedicated to fostering a culture of ethical research practices, ensuring participant safety, and generating impactful findings that contribute to evidence-based medicine and improve patient outcomes. Through its robust infrastructure and commitment to excellence, Western University plays a vital role in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Trial Officials
Harry Prapavessis, Ph.D
Principal Investigator
Western University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials